S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

实时更新: Coloplast A/S [CLPBY]

交易所: OTC 部门: Healthcare 工业: Medical Instruments & Supplies
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 0.00%

最后更新时间4 May 2024 @ 03:59

2.99% $ 12.41

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 03:59):

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally...

Stats
今日成交量 43 283.00
平均成交量 110 283
市值 27.79B
EPS $0.598 ( 2023-06-30 )
下一个收益日期 ( $0.0800 ) 2024-05-09
Last Dividend $0.0740 ( 2023-05-19 )
Next Dividend $0 ( N/A )
P/E 38.78
ATR14 $0.0210 (0.17%)

音量 相关性

長: -0.21 (neutral)
短: 0.88 (strong)
Signal:(45.765) Same movement expected

Coloplast A/S 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Coloplast A/S 相关性 - 货币/商品

The country flag 0.78
( moderate )
The country flag 0.73
( moderate )
The country flag 0.00
( neutral )
The country flag 0.73
( moderate )
The country flag -0.73
( moderate negative )

Coloplast A/S 财务报表

Annual 2023
营收: $24.50B
毛利润: $16.33B (66.64 %)
EPS: $22.21
FY 2023
营收: $24.50B
毛利润: $16.33B (66.64 %)
EPS: $22.21
FY 2022
营收: $22.58B
毛利润: $15.53B (68.78 %)
EPS: $22.15
FY 2021
营收: $19.43B
毛利润: $13.31B (68.53 %)
EPS: $2.27

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0.210
(N/A)
$0
(N/A)
$0.0740
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Coloplast A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.57 - average (85.65%) | Divividend Growth Potential Score: 4.27 - Stable (14.63%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0810 2021-05-14
Last Dividend $0.0740 2023-05-19
Next Dividend $0 N/A
Payout Date 2023-05-30
Next Payout Date N/A
# dividends 5 --
Total Paid Out $0.649 --
Avg. Dividend % Per Year 0.00% --
Score 2.68 --
Div. Sustainability Score 6.57
Div.Growth Potential Score 4.27
Div. Directional Score 5.42 --
Next Divdend (Est)
(2024-10-01)
$0.00796 Estimate 3.61 %
Dividend Stability
0.29 Very Poor
Dividend Score
2.68
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
UEPCP Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
JCYGY Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%
BDULF Ex Dividend Knight 2023-09-12 Annually 0 0.00%
REPYY Ex Dividend Knight 2023-07-03 Annually 0 0.00%
ENLAY Ex Dividend Knight 2023-07-24 Semi-Annually 0 0.00%
WTBDY Ex Dividend Junior 2023-05-25 Annually 0 0.00%
LGFRY Ex Dividend Junior 2023-07-06 Semi-Annually 0 0.00%
CCFC Ex Dividend Junior 2023-05-12 Quarterly 0 0.00%
SKLTY Ex Dividend Junior 2023-09-05 Annually 0 0.00%
FRRVY Ex Dividend Junior 2023-08-04 Sporadic 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1951.5006.119.16[0 - 0.5]
returnOnAssetsTTM0.1001.2006.667.99[0 - 0.3]
returnOnEquityTTM0.4241.5006.409.60[0.1 - 1]
payoutRatioTTM0.957-1.0000.433-0.433[0 - 1]
currentRatioTTM0.5320.800-2.34-1.871[1 - 3]
quickRatioTTM0.3240.800-2.80-2.24[0.8 - 2.5]
cashRatioTTM0.04841.500-0.842-1.263[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM9.311.0007.667.66[3 - 30]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
freeCashFlowPerShareTTM19.612.000.1950.389[0 - 20]
debtEquityRatioTTM1.430-1.5004.28-6.42[0 - 2.5]
grossProfitMarginTTM0.6671.0002.212.21[0.2 - 0.8]
operatingProfitMarginTTM0.2731.0006.536.53[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2561.0009.699.69[0.2 - 2]
assetTurnoverTTM0.5150.8009.907.92[0.5 - 2]
Total Score6.57

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3.861.0009.710[1 - 100]
returnOnEquityTTM0.4242.507.699.60[0.1 - 1.5]
freeCashFlowPerShareTTM19.612.003.460.389[0 - 30]
dividendYielPercentageTTM0.05161.5008.710[0 - 0.4]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
payoutRatioTTM0.9571.5000.433-0.433[0 - 1]
pegRatioTTM0.02891.500-3.140[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2211.0006.970[0.1 - 0.5]
Total Score4.27

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。